MLECW icon

Moolec Science SA Warrant

0.0234 USD
+0.0047
25.13%
Updated May 21, 11:57 AM EDT
1 day
25.13%
5 days
57.05%
1 month
-0.43%
3 months
-41.35%
6 months
-43.61%
Year to date
-16.43%
1 year
-66.48%
5 years
-88.86%
10 years
-88.86%
 

About: Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Employees: 52

0
Funds holding %
of 7,202 funds
Analysts bullish %

Fund manager confidence

Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)

0.07% more ownership

Funds ownership: 4.37% [Q4 2024] → 4.44% (+0.07%) [Q1 2025]

0% more funds holding

Funds holding: 16 [Q4 2024] → 16 (+0) [Q1 2025]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

65% less capital invested

Capital invested by funds: $48.9K [Q4 2024] → $17.3K (-$31.6K) [Q1 2025]

Research analyst outlook

We haven’t received any recent analyst ratings for MLECW.

Financial journalist opinion

Neutral
Seeking Alpha
7 months ago
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q4 2024 Earnings Conference Call October 2, 2024 8:30 AM ET Company Participants Gaston Paladini - Chief Executive Officer Jose Lopez Lecube - Chief Financial Officer Martin Salinas - Chief Technology Officer Amit Dhingra - Chief Science Officer Bill Zima - ICR Strategic Communications Conference Call Participants Scott Fortune - Roth Capital Operator Good morning and welcome to Moolec Science's fourth quarter and full fiscal year 2024 conference call. My name is Bill Zima of ICR Strategic Communications and Advisory.
Moolec Science (MLEC) Q4 2024 Earnings Call Transcript
Neutral
Seeking Alpha
11 months ago
Moolec Science SA (MLEC) Q3 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q3 2024 Earnings Conference Call May 30, 2024 8:30 AM ET Company Participants Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO Bruce William - Plant Scientist Conference Call Participants Thomas McGovern - Maxim Group Scott Fortune - Roth MKM Bruce William This morning, you will hear from Gaston Paladini, Chief Executive Officer and Co-Founder of Moolec Science, together with Jose Lopez Lecube, Chief Financial Officer and Amit Dhingra, Chief Science Officer. In today's call, we will be referring to a presentation that is available on the company's Investor Relations website.
Positive
InvestorPlace
1 year ago
Why Is Moolec Science (MLEC) Stock Up 121% Today?
Moolec Science (NASDAQ: MLEC ) stock is taking off on Monday after the company got approval from the Food and Drug Administration (FDA) for its plant-grown animal proteins. According to a press release from the company, this covers its genetically engineered soybean that accumulates animal proteins.
Positive
InvestorPlace
1 year ago
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Moolec Science (NASDAQ: MLEC ) stock is getting a boost on Thursday despite a lack of news from the science-based food ingredient company. There are no new press releases or filings with the Securities and Exchange Commission (SEC) that explain why the stock is rising today.
Why Is Moolec Science (MLEC) Stock Up 40% Today?
Neutral
Seeking Alpha
1 year ago
Moolec Science SA (MLEC) Q1 2024 Earnings Call Transcript
Moolec Science SA (NASDAQ:MLEC ) Q1 2024 Earnings Conference Call December 14, 2023 8:30 AM ET Company Participants Michael Bowen - ICR's, Strategic Communications and Advisory Gaston Paladini - CEO and Co-Founder Amit Dhingra - Chief Science Officer Jose Lopez Lecube - CFO Conference Call Participants Brian Wright - ROTH MKM Tom McGovern - Maxim Group Michael Bowen Good morning, and welcome to Moolec's Conference Call. My name is Michael Bowen, from ICR's, Strategic Communications and Advisory.
Moolec Science SA (MLEC) Q1 2024 Earnings Call Transcript
Charts implemented using Lightweight Charts™